172 related articles for article (PubMed ID: 36093331)
1. Differences in Immunoglobulin G Glycosylation Between Influenza and COVID-19 Patients.
Kljaković-Gašpić Batinjan M; Petrović T; Vučković F; Hadžibegović I; Radovani B; Jurin I; Đerek L; Huljev E; Markotić A; Lukšić I; Trbojević-Akmačić I; Lauc G; Gudelj I; Čivljak R
Engineering (Beijing); 2022 Sep; ():. PubMed ID: 36093331
[TBL] [Abstract][Full Text] [Related]
2. Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid.
Wuhrer M; Selman MH; McDonnell LA; Kümpfel T; Derfuss T; Khademi M; Olsson T; Hohlfeld R; Meinl E; Krumbholz M
J Neuroinflammation; 2015 Dec; 12():235. PubMed ID: 26683050
[TBL] [Abstract][Full Text] [Related]
3. IgG N-glycome changes during the course of severe COVID-19: An observational study.
Petrović T; Vijay A; Vučković F; Trbojević-Akmačić I; Ollivere BJ; Marjanović D; Bego T; Prnjavorac B; Đerek L; Markotić A; Lukšić I; Jurin I; Valdes AM; Hadžibegović I; Lauc G
EBioMedicine; 2022 Jul; 81():104101. PubMed ID: 35773089
[TBL] [Abstract][Full Text] [Related]
4. Distinct N-Linked Immunoglobulin G Glycosylation Patterns Are Associated With Chronic Pathology and Asymptomatic Infections in Human Lymphatic Filariasis.
Adjobimey T; Hoerauf A
Front Immunol; 2022; 13():790895. PubMed ID: 35401511
[TBL] [Abstract][Full Text] [Related]
5. Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination.
Selman MH; de Jong SE; Soonawala D; Kroon FP; Adegnika AA; Deelder AM; Hokke CH; Yazdanbakhsh M; Wuhrer M
Mol Cell Proteomics; 2012 Apr; 11(4):M111.014563. PubMed ID: 22184099
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of
Zou G; Kosikova M; Kim SR; Kotian S; Wu WW; Shen R; Powers DN; Agarabi C; Xie H; Ju T
J Biol Chem; 2018 Dec; 293(50):19277-19289. PubMed ID: 30315103
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes.
Bondt A; Rombouts Y; Selman MH; Hensbergen PJ; Reiding KR; Hazes JM; Dolhain RJ; Wuhrer M
Mol Cell Proteomics; 2014 Nov; 13(11):3029-39. PubMed ID: 25004930
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the Fc glycosylation of fetal and maternal immunoglobulin G.
Einarsdottir HK; Selman MH; Kapur R; Scherjon S; Koeleman CA; Deelder AM; van der Schoot CE; Vidarsson G; Wuhrer M
Glycoconj J; 2013 Feb; 30(2):147-57. PubMed ID: 22572841
[TBL] [Abstract][Full Text] [Related]
9. IgG N-glycans.
Liu S; Liu X
Adv Clin Chem; 2021; 105():1-47. PubMed ID: 34809825
[TBL] [Abstract][Full Text] [Related]
10. Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells.
Hills AE; Patel A; Boyd P; James DC
Biotechnol Bioeng; 2001 Oct; 75(2):239-51. PubMed ID: 11536148
[TBL] [Abstract][Full Text] [Related]
11. IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis.
Selman MH; Niks EH; Titulaer MJ; Verschuuren JJ; Wuhrer M; Deelder AM
J Proteome Res; 2011 Jan; 10(1):143-52. PubMed ID: 20672848
[TBL] [Abstract][Full Text] [Related]
12. Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans.
Dekkers G; Plomp R; Koeleman CA; Visser R; von Horsten HH; Sandig V; Rispens T; Wuhrer M; Vidarsson G
Sci Rep; 2016 Nov; 6():36964. PubMed ID: 27872474
[TBL] [Abstract][Full Text] [Related]
13. High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations.
Pucić M; Knezević A; Vidic J; Adamczyk B; Novokmet M; Polasek O; Gornik O; Supraha-Goreta S; Wormald MR; Redzić I; Campbell H; Wright A; Hastie ND; Wilson JF; Rudan I; Wuhrer M; Rudd PM; Josić D; Lauc G
Mol Cell Proteomics; 2011 Oct; 10(10):M111.010090. PubMed ID: 21653738
[TBL] [Abstract][Full Text] [Related]
14. Association between immunoglobulin G N-glycosylation and lupus nephritis in female patients with systemic lupus erythematosus: a case-control study.
Lu X; Wang L; Wang M; Li Y; Zhao Q; Shi Y; Zhang Y; Wang Y; Wang W; Ji L; Hou H; Li D
Front Immunol; 2023; 14():1257906. PubMed ID: 37809087
[TBL] [Abstract][Full Text] [Related]
15. Changes of IgG
Trzos S; Link-Lenczowski P; Sokołowski G; Pocheć E
Front Immunol; 2022; 13():841710. PubMed ID: 35370997
[TBL] [Abstract][Full Text] [Related]
16. Effects of sialic acid linkage on antibody-fragment crystallizable receptor binding and antibody dependent cytotoxicity depend on levels of fucosylation/bisecting.
Thomann M; Malik S; Kuhne F; Avenal C; Plath F; Bonnington L; Reusch D; Bulau P; Cymer F
Bioanalysis; 2019 Aug; 11(15):1437-1449. PubMed ID: 31490109
[No Abstract] [Full Text] [Related]
17. Enhanced sialylation of a human chimeric IgG1 variant produced in human and rodent cell lines.
Mimura Y; Kelly RM; Unwin L; Albrecht S; Jefferis R; Goodall M; Mizukami Y; Mimura-Kimura Y; Matsumoto T; Ueoka H; Rudd PM
J Immunol Methods; 2016 Jan; 428():30-6. PubMed ID: 26627984
[TBL] [Abstract][Full Text] [Related]
18. Glycoengineering of therapeutic glycoproteins: in vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues.
Raju TS; Briggs JB; Chamow SM; Winkler ME; Jones AJ
Biochemistry; 2001 Jul; 40(30):8868-76. PubMed ID: 11467948
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study.
van de Geijn FE; Wuhrer M; Selman MH; Willemsen SP; de Man YA; Deelder AM; Hazes JM; Dolhain RJ
Arthritis Res Ther; 2009; 11(6):R193. PubMed ID: 20015375
[TBL] [Abstract][Full Text] [Related]
20. Association of IgG N-glycomics with prevalent and incident type 2 diabetes mellitus from the paradigm of predictive, preventive, and personalized medicine standpoint.
Meng X; Wang F; Gao X; Wang B; Xu X; Wang Y; Wang W; Zeng Q
EPMA J; 2023 Mar; 14(1):1-20. PubMed ID: 36866157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
